Dror Bashan is President and Chief Executive Officer of Protalix BioTherapeutics, Inc. (PLX). The company reported total compensation of $1,166,934 for fiscal year 2025.
| Salary | $401,836 |
|---|---|
| Bonus | $279,491 |
| Stock awards | $0 |
| Option awards | $190,015 |
| Non-equity incentive plan | $169,017 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $126,575 |
| Total | $1,166,934 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Protalix BioTherapeutics, Inc. filed April 30, 2026, accession 0001104659-26-053016.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $401,836 | $279,491 | $0 | $190,015 | $169,017 | $0 | $126,575 | $1,166,934 |
| FY2024 | President and Chief Executive Officer | $374,108 | $0 | $918,318 | $118,803 | $116,563 | — | $0 | $1,527,792 |
Totals as disclosed in each year's own compensation disclosure for Protalix BioTherapeutics, Inc..
| Peer-group chief executive median | $6,323,334 |
|---|---|
| Difference from that median | $-5,156,399 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 2 |
Medians and percentiles are computed across the peer group Protalix BioTherapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Dror Bashan this page | President and Chief Executive Officer | $1,166,934 |
| Eyal Rubin | Senior Vice President and Chief Financial Officer | $832,461 |
| Yaron Naos | Senior Vice President, Chief Operating Officer | $575,769 |
| Gilad Mamlok | Senior Vice President and Chief Financial Officer | $405,225 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Protalix BioTherapeutics, Inc. compensation brief.
Dror Bashan's compensation sits inside Protalix BioTherapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.